Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KLF16-AS1 is an antisense long non-coding RNA (lncRNA) transcribed from the KLF16 locus. It is not a protein-coding gene, receptor, enzyme, transporter, or transcription factor. There is no evidence from the provided search results that it is itself a direct therapeutic target, nor are its molecular functions or disease roles clearly established based on current referenced literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KLF16 antisense RNA 1 (KLF16-AS1).